SCHEMBL29972876

SCHEMBL29972876

Fc1cn(-c2ccc(C3OCCO3)cn2)nc1I

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27082391 1.00 MEN1 (0.32) MEN1KMT2ACYP11B1CYP11B2
SCHEMBL24409256 0.84 RAB9A (0.32) MEN1KMT2ACYP11B1CYP11B2
SCHEMBL29972943 0.79 CYP11B1 (0.31) CYP11B1CYP11B2
SCHEMBL27082322 0.79 CYP11B1 (0.31) CYP11B1CYP11B2
SCHEMBL27082404 0.77 KDM4E (0.35) KMT2A
SCHEMBL29973045 0.77 KDM4E (0.35) KMT2A
SCHEMBL30630824 0.74 GCG (0.36)
SCHEMBL24409267 0.74 GCG (0.36)
SCHEMBL24409184 0.73 SLC34A1 (0.31)
SCHEMBL28619768 0.71 MEN1 (0.31) MEN1KMT2ACYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117327078-A Heterocyclic compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-02 CN disclosed
CN-117263945-A Heterocyclic compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-12-22 CN disclosed
CN-113316578-B Heterocyclic compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-10-31 CN disclosed
CN-116801882-A Use and method of heterocyclic compounds for treating diseases associated with kinase resistant mutations 四川科伦博泰生物医药股份有限公司 2023-09-22 CN disclosed
WO-2022199503-A1 USE OF HETEROCYCLIC COMPOUND IN TREATING DISEASES RELATED TO KINASE DRUG-RESISTANT MUTATION AND METHOD THEREFOR 四川科伦博泰生物医药股份有限公司 2022-09-29 WO disclosed